Federal Register / Vol. 65, No. 86 / Wednesday, May 3, 2000 / Notices 25733

CFR Section No. of respondents

No. of

responses/ respondent

Avg. burden/

response (in

hrs.)

72.3(e) .......................................................................................................................................... 50 1 6/60

72.3(f) ........................................................................................................................................... 200 10 12/60

72.4 .............................................................................................................................................. 20 1 12/60

72.6(a) .......................................................................................................................................... 100 1 210/60

72.6(d) .......................................................................................................................................... 300 2 30/60

72.6(e) .......................................................................................................................................... 300 2 10/60

72.6(f) ........................................................................................................................................... 300 2 10/60

Dated: April 26, 2000.

Charles W. Gollmar,

Acting Associate Director for Policy,

Planning, and Evaluation, Centers for Disease

Control and Prevention (CDC).

[FR Doc. 00–10979 Filed 5–2–00; 8:45 am]

BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Centers for Disease Control and

Prevention

[30 DAY–28–00]

Agency Forms Undergoing Paperwork

Reduction Act Review

The Centers for Disease Control and

Prevention (CDC) publishes a list of

information collection requests under

review by the Office of Management and

Budget (OMB) in compliance with the

Paperwork Reduction Act (44 U.S.C.

chapter 35). To request a copy of these

requests, call the CDC Reports Clearance

Officer at (404) 639–7090. Send written

comments to CDC, Desk Officer; Human

Resources and Housing Branch, New

Executive Office Building, Room 10235;

Washington, DC 20503. Written

comments should be received within 30

days of this notice.

Proposed Projects

1. Chronic Fatigue Syndrome (CFS)

Surveillance and Related Studies,

Prevalence and Incidence of Fatiguing

Illnesses in Sedgwick County, Kansas

(0920–0401)—Extension—The Centers

for Disease Control and Prevention

(CDC) A Population-Based CFS Study

was done previously in Kansas in 1997.

Data from this cross-sectional, randomdigit-dial survey of prolonged fatiguing

illness in Wichita, Kansas will be added

to the data previously obtained during

the past 24 months from this

population.

The proposed study continues the

Sedgwick County study using identical

methodology and data collection

instruments. Beginning with a randomdigit-dial telephone survey to identify

previously identified fatigued and nonfatigued individuals, followed by a

detailed telephone interview to obtain

additional data on participants’ health

status during the last 12-month period.

Study objectives remain to refine

estimates of CFS in Wichita, identify

similarities and differences among

fatigued and non-fatigued subjects and

to describe the clinical course of

fatiguing illness in the population. Total

annual hours burden are 2,066.

Form name No. of respondents

No. of responses/respondentAvg. burden/

response

(in hrs.)

Telephone Questionnaire ............................................................................................................ 4,500 1 20/60

Self-Administered Questionnaire—Initially Fatigued Adult .......................................................... 75 1 20/60

Self-Administered Questionnaire—Follow-up Fatigued Adult ..................................................... 147 1 20/60

Self-Administered Questionnaire—Non Fatigued Adult .............................................................. 93 1 30/60

Self-Administered Questionnaire—Initially Fatigued Adolescent ................................................ 2 1 30/60

Self-Administered Questionnaire—Parent of Initially Fatigued Adolescent ................................ 2 1 30/60

Self-Administered Questionnaire—Follow-up Fatigued Adolescent ............................................ 2 1 30/60

Self-Administered Questionnaire—Parent of Follow-up Fatigued Adolescent ............................ 2 1 30/60

Self-Administered Questionnaire—Non-Fatigued Adolescent ..................................................... 1 1 30/60

Self-Administered Questionnaire—Parent of Non-Fatigued Adolescent ..................................... 1 1 30/60

Symptom Questionnaire—Initially Fatigued Adult ....................................................................... 75 1 10/60

Symptom Questionnaire—Follow-up Fatigued Adult .................................................................. 147 1 10/60

Symptom Questionnaire—Initially Fatigued Adolescent and Parent of Fatigued Adolescent .... 4 1 10/60

Symptom Questionnaire—Follow-up Fatigued Adolescent and Parent of Fatigued Adolescent 4 1 10/60

Course of Fatiguing Illness Questionnaire .................................................................................. 208 1 4/60

Diagnostic Interview Schedule—Adults Questionnaire ............................................................... 315 1 45/60

Diagnostic Interview Schedule—Parent Version ......................................................................... 5 1 45/60

Diagnostic Interview Schedule—Child Version ........................................................................... 5 1 45/60

Sleep Disorders Questionnaire—Fatigued Adults ....................................................................... 222 1 7/60

Fatigue Questionnaire—Adults and Adolescents ........................................................................ 226 1 15/60

Fatigue Questionnaire—Parent of Adolescent ............................................................................ 4 1 15/60

SF–36 Questionnaire ................................................................................................................... 320 1 11/60

25734 Federal Register / Vol. 65, No. 86 / Wednesday, May 3, 2000 / Notices

Dated: April 26, 2000.

Charles W. Gollmar,

Acting Associate Director for Policy,

Planning, and Evaluation, Centers for Disease

Control and Prevention (CDC).

[FR Doc. 00–10980 Filed 5–2–00; 8:45 am]

BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Centers for Disease Control and

Prevention

[30 DAY–25–00]

Agency Forms Undergoing Paperwork

Reduction Act Review

The Centers for Disease Control and

Prevention (CDC) publishes a list of

information collection requests under

review by the Office of Management and

Budget (OMB) in compliance with the

Paperwork Reduction Act (44 U.S.C.

chapter 35). To request a copy of these

requests, call the CDC Reports Clearance

Officer at (404) 639–7090. Send written

comments to CDC, Desk Officer; Human

Resources and Housing Branch, New

Executive Office Building, Room 10235;

Washington, DC 20503. Written

comments should be received within 30

days of this notice.

Proposed Projects

1. Surveillance and Evaluation of

Blood Donors Positive for Human

Immunodeficiency Virus (HIV)

Antibody or HIV Antigen (0920–0329)—

Extension—National Center for HIV,

STD, and TB Prevention (NCHSTP). In

1987, the President directed the

Department of Health and Human

Services (DHHS) to determine the

nationwide incidence of, to predict the

future of, and to determine the extent to

which human immunodeficiency virus

(HIV) is present in various segments of

our population. In response, CDC

formed an epidemiological team to

summarize existing information. An

extensive review of published and

unpublished data led to the conclusion

that even though there is information

suggesting a very large number of

Americans were infected, there was no

substitute for carefully and scientifically

obtained incidence and prevalence data.

The need to monitor HIV seroprevalence

existed on the national and at the state

and local levels for public health

management: targeting and evaluating

prevention programs, planning future

health care needs and determining

health policy.

On a national basis, HIV

seroprevalence projects in 1987

consisted of monitoring the HIV status

of: Civilian applicants for military

service; blood donors, including followup risk factor evaluation in

seropositives; and Job Corps entrants.

HIV prevalence was studied in settings

of special public health interest

including selected colleges and prisons,

among health care workers in hospital

emergency rooms and among Native

Americans and homeless persons. Other

national data sources were examined,

such as cohort studies of groups at risk,

including homosexual and bisexual men

and IV drug users, providing

information on knowledge of AIDS and

risk behaviors, changes in behavior, and

incidence of HIV infection.

In 1987, OMB approved the Family of

HIV Seroprevalence Surveys (0920–

0232). These surveys included seven

seroprevalence surveys that involved

interaction with individuals (nonblinded surveys). One of these surveys

was the surveillance and evaluation of

blood donors.

The objectives of this study are to: (1)

Estimate the prevalence and incidence

of HIV infection among blood donors at

participating blood centers; (2) evaluate

the characteristics of infected donors to

strengthen the effectiveness of the donor

screening and deferral processes; (3)

analyze the risk behavior characteristics

of infected donors to assess distribution

and trends of HIV; (4) monitor

additional human immunodeficiency

viruses, HIV genetic variation, and other

infections relevant to the epidemiology

of HIV among U.S. blood donors and

seroconverted recipients; (5) estimate

the risk of HIV transmission from

screened blood; (6) and evaluate new

tests to decrease transmission by

window period donors.

In 1993 and 1996, OMB again

approved for 3 years each, the

surveillance and evaluation of blood

donors who test positive for Human

Immunodeficiency Virus (HIV)

Antibody and their needle-sharing and

sexual partners (0920–0329). This

request is for an additional 3-year

approval. The CDC anticipates 125

positive donors will enroll annually in

this study (based upon previous 3 year

enrollment rates and epidemiological

progress of the disease). The interview

takes approximately 1 hour to complete

for those who agree to the interview and

10 minutes to complete for those who

refuse to enroll. The Annual Burden is

140.

Respondents No. of

respondents

No. of

responses/respondent

Avg. burden

response (in

hours)

Blood donors (interviewed) .......................................................................................................... 125 1 1.0

Blood donors (refuse interview) ................................................................................................... 92 1 10/60

Dated: April 26, 2000.

Charles W. Gollmar,

Acting Associate Director for Policy,

Planning, and Evaluation, Centers for Disease

Control and Prevention (CDC).

[FR Doc. 00–10981 Filed 5–2–00; 8:45 am]

BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Administration for Children and

Families

Proposed Information Collection

Activity; Comment Request

Proposed Projects

Title: Information Collection Items in

the Head Start Performance Standards

(current rule).

OMB No.: 0970–0148.

Description: The Head Start

Performance Standards are regulations

which establish standards for Head Start

grantee and delegate agencies to follow

to administer quality programs as

required by law. Local programs are

monitored for compliance with these

standards. The information collection

aspects of the Performance Standards

are one part of the many actions that

local agencies must take to ensure they

administer quality programs. Almost all

these information collections items are

recordkeeping requirements such as

recording: Nutrition assessment data,

family partnership development, and

regular volunteer screening for

tuberculosis. These records are intended